Cargando…

Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS

INTRODUCTION: In ankylosing spondylitis (AS), joint remodeling leading to joint ankylosis involves cartilage fusion. Here, we analyzed whether chondrocyte hypertrophy is involved in cartilage fusion and subsequent joint remodeling in AS. METHODS: We assessed the expression of chondrocyte hypertrophy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleil, Janine, Sieper, Joachim, Maier, Rene, Schlichting, Uwe, Hempfing, Axel, Syrbe, Uta, Appel, Heiner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506408/
https://www.ncbi.nlm.nih.gov/pubmed/26123554
http://dx.doi.org/10.1186/s13075-015-0675-5
_version_ 1782381678443888640
author Bleil, Janine
Sieper, Joachim
Maier, Rene
Schlichting, Uwe
Hempfing, Axel
Syrbe, Uta
Appel, Heiner
author_facet Bleil, Janine
Sieper, Joachim
Maier, Rene
Schlichting, Uwe
Hempfing, Axel
Syrbe, Uta
Appel, Heiner
author_sort Bleil, Janine
collection PubMed
description INTRODUCTION: In ankylosing spondylitis (AS), joint remodeling leading to joint ankylosis involves cartilage fusion. Here, we analyzed whether chondrocyte hypertrophy is involved in cartilage fusion and subsequent joint remodeling in AS. METHODS: We assessed the expression of chondrocyte hypertrophy markers runt-related transcription factor 2 (Runx2), type X collagen (COL10), matrix metalloproteinase 13 (MMP13), osteocalcin and beta-catenin and the expression of positive bone morphogenic proteins (BMPs) and negative regulators (dickkopf-1 (DKK-1)), sclerostin, (wingless inhibitory factor 1 (wif-1)) of chondrocyte hypertrophy in the cartilage of facet joints from patients with AS or osteoarthritis (OA) and from autopsy controls (CO) by immunohistochemistry. Sex determining region Y (SRY)-box 9 (Sox9) and type II collagen (COL2) expression was assessed as indicators of chondrocyte integrity and function. RESULTS: The percentage of hypertrophic chondrocytes expressing Runx2, COL10, MMP13, osteocalcin or beta-catenin was significantly increased in OA but not in AS joints compared to CO joints. Frequencies of sclerostin-positive and DKK-1-positive chondrocytes were similar in AS and CO. In contrast, wif-1- but also BMP-2- and BMP-7-expressing and Sox9-expressing chondrocytes were drastically reduced in AS joints compared to CO as well as OA joints whereas the percentage of COL2-expressing chondrocytes was significantly higher in AS joints compared to CO joints. CONCLUSIONS: We found no evidence for chondrocyte hypertrophy within hyaline cartilage of AS joints even in the presence of reduced expression of the wnt inhibitor wif-1 suggesting that chondrocyte hypertrophy is not a predominant pathway involved in joint fusion and remodeling in AS. In contrast, the reduced expression of Sox9, BMP-2 and BMP-7 concomitantly with induced COL2 expression rather point to disturbed cartilage homeostasis promoting cartilage degeneration in AS.
format Online
Article
Text
id pubmed-4506408
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45064082015-07-19 Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS Bleil, Janine Sieper, Joachim Maier, Rene Schlichting, Uwe Hempfing, Axel Syrbe, Uta Appel, Heiner Arthritis Res Ther Research Article INTRODUCTION: In ankylosing spondylitis (AS), joint remodeling leading to joint ankylosis involves cartilage fusion. Here, we analyzed whether chondrocyte hypertrophy is involved in cartilage fusion and subsequent joint remodeling in AS. METHODS: We assessed the expression of chondrocyte hypertrophy markers runt-related transcription factor 2 (Runx2), type X collagen (COL10), matrix metalloproteinase 13 (MMP13), osteocalcin and beta-catenin and the expression of positive bone morphogenic proteins (BMPs) and negative regulators (dickkopf-1 (DKK-1)), sclerostin, (wingless inhibitory factor 1 (wif-1)) of chondrocyte hypertrophy in the cartilage of facet joints from patients with AS or osteoarthritis (OA) and from autopsy controls (CO) by immunohistochemistry. Sex determining region Y (SRY)-box 9 (Sox9) and type II collagen (COL2) expression was assessed as indicators of chondrocyte integrity and function. RESULTS: The percentage of hypertrophic chondrocytes expressing Runx2, COL10, MMP13, osteocalcin or beta-catenin was significantly increased in OA but not in AS joints compared to CO joints. Frequencies of sclerostin-positive and DKK-1-positive chondrocytes were similar in AS and CO. In contrast, wif-1- but also BMP-2- and BMP-7-expressing and Sox9-expressing chondrocytes were drastically reduced in AS joints compared to CO as well as OA joints whereas the percentage of COL2-expressing chondrocytes was significantly higher in AS joints compared to CO joints. CONCLUSIONS: We found no evidence for chondrocyte hypertrophy within hyaline cartilage of AS joints even in the presence of reduced expression of the wnt inhibitor wif-1 suggesting that chondrocyte hypertrophy is not a predominant pathway involved in joint fusion and remodeling in AS. In contrast, the reduced expression of Sox9, BMP-2 and BMP-7 concomitantly with induced COL2 expression rather point to disturbed cartilage homeostasis promoting cartilage degeneration in AS. BioMed Central 2015-07-17 2015 /pmc/articles/PMC4506408/ /pubmed/26123554 http://dx.doi.org/10.1186/s13075-015-0675-5 Text en © Bleil et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bleil, Janine
Sieper, Joachim
Maier, Rene
Schlichting, Uwe
Hempfing, Axel
Syrbe, Uta
Appel, Heiner
Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS
title Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS
title_full Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS
title_fullStr Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS
title_full_unstemmed Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS
title_short Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS
title_sort cartilage in facet joints of patients with ankylosing spondylitis (as) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in as
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506408/
https://www.ncbi.nlm.nih.gov/pubmed/26123554
http://dx.doi.org/10.1186/s13075-015-0675-5
work_keys_str_mv AT bleiljanine cartilageinfacetjointsofpatientswithankylosingspondylitisasshowssignsofcartilagedegenerationratherthanchondrocytehypertrophyimplicationsforjointremodelinginas
AT sieperjoachim cartilageinfacetjointsofpatientswithankylosingspondylitisasshowssignsofcartilagedegenerationratherthanchondrocytehypertrophyimplicationsforjointremodelinginas
AT maierrene cartilageinfacetjointsofpatientswithankylosingspondylitisasshowssignsofcartilagedegenerationratherthanchondrocytehypertrophyimplicationsforjointremodelinginas
AT schlichtinguwe cartilageinfacetjointsofpatientswithankylosingspondylitisasshowssignsofcartilagedegenerationratherthanchondrocytehypertrophyimplicationsforjointremodelinginas
AT hempfingaxel cartilageinfacetjointsofpatientswithankylosingspondylitisasshowssignsofcartilagedegenerationratherthanchondrocytehypertrophyimplicationsforjointremodelinginas
AT syrbeuta cartilageinfacetjointsofpatientswithankylosingspondylitisasshowssignsofcartilagedegenerationratherthanchondrocytehypertrophyimplicationsforjointremodelinginas
AT appelheiner cartilageinfacetjointsofpatientswithankylosingspondylitisasshowssignsofcartilagedegenerationratherthanchondrocytehypertrophyimplicationsforjointremodelinginas